Showing 5861-5870 of 21466 results for "".
- Exploring Biomarkers for Metabolic Complications in NAFLD: The Uric Acid-to-Creatinine Ratiohttps://reachmd.com/news/exploring-biomarkers-for-metabolic-complications-in-nafld-the-uric-acid-to-creatinine-ratio/2484471/According to a recent study, uric acid-to-creatinine ratio (SUA/Cr) identifies metabolic risk and may support screening and risk stratification in patients with non-alcoholic
- Tralokinumab Maintains Efficacy in Hand AD Through 32 Weekshttps://reachmd.com/news/tralokinumab-maintains-efficacy-in-hand-ad-through-32-weeks/2484484/LEO Pharma has announced positive 32-week topline results from its ADHAND trial, a phase 3b study evaluating tralokinumab in adults with moderate-to-severe atopic dermatitis (AD) with hand involvement. According to a press rele
- Unveiling FGD3: A New Ally in the Fight Against Breast Cancerhttps://reachmd.com/news/unveiling-fgd3-a-new-ally-in-the-fight-against-breast-cancer/2484466/FGD3 sensitizes breast tumors to chemotherapy and immunotherapy in preclinical models by triggering cancer-cell swelling and membrane rupture
- Exploring Slowly Expanding Lesions in Pediatric-Onset Multiple Sclerosishttps://reachmd.com/news/exploring-slowly-expanding-lesions-in-pediatric-onset-multiple-sclerosis/2484449/Detection of slowly expanding lesions (SELs) in pediatric-onset MS identifies a reproducible imaging correlate linked to accelerated tissue loss and worse structural ou
- Preeclampsia Prediction: The Role of Placental Biomarkers in Enhancing Maternal Carehttps://reachmd.com/news/preeclampsia-prediction-the-role-of-placental-biomarkers-in-enhancing-maternal-care/2484470/Placental viral-derived enhancers may enable earlier risk stratification for preeclampsia; a multicenter analysis identifies 87 such enhancers and nominates EPS8L1 as a circulating biomarker candidate. The multicenter case-control study
- SEZ6: An Emerging Role in Neuroendocrine Carcinomashttps://reachmd.com/news/sez6-an-emerging-role-in-neuroendocrine-carcinomas/2484460/SEZ6 is a neuronal membrane protein now implicated in high-grade neuroendocrine carcinomas. These tumors are clinically aggressive and lack durable systemic therapies, heightening the
- Systematic Review Examines Hematoma Reduction Techniques in Faceliftshttps://reachmd.com/news/systematic-review-examines-hematoma-reduction-techniques-in-facelifts/2484473/A new systematic review and meta-analysis published in Facial Plastic Surgery & Aesthetic Medicine underscores the incidence of hematoma after rhytidectomy and evaluates commonly used adjunctive techniques aimed at reducing this complication. The analysis focused on patients undergoi
- Novartis Launches Head-to-Head Trial of Remibrutinib vs Dupilumabhttps://reachmd.com/news/novartis-launches-head-to-head-trial-of-remibrutinib-vs-dupilumab/2484430/Novartis, manufacturers of remibrutinib (Rhapsido), announced the launch of a US-based phase 3b clinical trial for the evaluation of early efficacy and safety of oral remibrutinib compared to injectable dupilumab in adults with chronic spontaneous urticaria (CSU) in
- Unlocking the Therapeutic Potential of Connexin 43 in Endothelial Healing Post-Surgeryhttps://reachmd.com/news/unlocking-the-therapeutic-potential-of-connexin-43-in-endothelial-healing-post-surgery/2484446/A recent study found that connexin 43 is vital in endothelial wound healing after surgical injury. Its expr
- Transperineal Prostate Biopsy: A Safer Diagnostic Alternative?https://reachmd.com/news/transperineal-prostate-biopsy-a-safer-diagnostic-alternative/2484445/At IURES 2025, researchers reported that transperineal prostate biopsy performed under local anaesthes